Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Phio Pharmaceuticals Corp. - Common Stock
(NQ:
PHIO
)
1.270
-0.030 (-2.31%)
Streaming Delayed Price
Updated: 12:48 PM EST, Nov 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
240,523
Open
1.300
Bid (Size)
1.270 (1,000)
Ask (Size)
1.280 (2,300)
Prev. Close
1.300
Today's Range
1.260 - 1.310
52wk Range
0.9657 - 9.790
Shares Outstanding
5,726,750
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
Today 8:45 EST
King of Prussia, Pennsylvania--(Newsfile Corp. - November 17, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical...
Via
Newsfile
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
Clinical Trial has Advanced to Fifth and Final Cohort at Maximum Dose of INSTASYL PH-762 in Skin Cancer Trial Positive...
Via
Newsfile
Performance
YTD
-33.2%
-33.2%
1 Month
-39.8%
-39.8%
3 Month
-40.9%
-40.9%
6 Month
-30.6%
-30.6%
1 Year
-44.1%
-44.1%
More News
Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 13, 2025
Via
Benzinga
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762
November 07, 2025
Via
Newsfile
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
November 07, 2025
Via
Newsfile
Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge Science into Next-Generation Cancer Therapies – More Stocks Inside
November 03, 2025
Via
AB Newswire
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
These stocks are the most active in today's session
↗
November 03, 2025
Via
Chartmill
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
November 03, 2025
Via
Newsfile
Why Is Phio Pharmaceuticals Stock Soaring Today?
↗
November 03, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session.
↗
November 03, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 03, 2025
Via
Benzinga
Gapping stocks in Monday's session
↗
November 03, 2025
Via
Chartmill
Discover the top movers in Monday's pre-market session.
↗
November 03, 2025
Via
Chartmill
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
November 03, 2025
Via
Newsfile
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
October 31, 2025
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
October 21, 2025
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
September 23, 2025
Via
Newsfile
Phio Pharmaceuticals to Present at the Life Sciences Future Conference
September 18, 2025
Via
Newsfile
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
Via
Newsfile
Phio Posts Wider Loss in Fiscal Q2
↗
August 14, 2025
Via
The Motley Fool
Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
Via
Newsfile
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds
July 25, 2025
Via
Newsfile
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 25, 2025
Via
Benzinga
Frequently Asked Questions
Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.270
When was Phio Pharmaceuticals Corp. - Common Stock last traded?
The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 11/17/25 12:48 PM ET
What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 7.27M
How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
Phio Pharmaceuticals Corp. - Common Stock has 7M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.